Thursday, July 19, 2007
A new medication to stimulate bone growth, human fibroblast growth factor (FGF-1), appears to have been successful in mice, according to manufacturer CardioVascular BioTherapeutics. They say the new drug is 20 times more potent than Forteo, the drug currently used to stimulate bone formation.
Many other osteoporosis medicines, such as bisphosponates, work by stopping the process of bone breakdown rather than stimulating growth directly. Let's keep our eyes on this promising research as it winds it way through the process!
